Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07525635
EARLY_PHASE1
Aspirin Dosing in Pregnancy
Sponsor: NYU Langone Health
View on ClinicalTrials.gov
Summary
The purpose of this study is assess platelet phenotypes based on aspirin dosing in pregnant patients at risk for the development preeclampsia who are taking 81mg twice a day aspirin. Blood samples will be collected approximately 4 weeks after initiation of aspirin to evaluate the platelet phenotype during pregnancy in patients.
Official title: Aspirin Dosing and Platelet Phenotype in Pregnancy
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-04-27
Completion Date
2028-02-20
Last Updated
2026-05-18
Healthy Volunteers
No
Conditions
Interventions
DRUG
Aspirin
81mg twice a day (162mg total)
Locations (1)
NYU Langone Health
New York, New York, United States